2019 Advisory Board

Irina Petrache is Professor of Medicine at National Jewish Health and University of Colorado, Denver, CO. Dr. Petrache received her medical degree from the “Carol Davila” University of Medicine and Pharmacy in Bucharest, Romania and received postgraduate training in Internal Medicine at Saint Luke’s/St Vincent Medical Center/Case Western Reserve University in Cleveland, OH; and in…

Dr. Colin Reisner is Senior Vice President and Head of Late Stage RIA (Respiratory, Inflammation & Autoimmunity), BioPharmaceuticals R&D, AstraZeneca. He is an innovative leader with more than 20 years of international experience at top-tier companies, having previously workred at Boehringer Ingelheim, GSK and Novartis. Colin has extensive experience in both large and small companies,…

Pliant CEO Bernard Coulie, MD, PhD brings to the company more than 15 years of senior leadership experience and drug development expertise. He joined Pliant from ActoGeniX (acquired by Intrexon Corporation in February 2015), where he was CEO, Chief Medical Officer and Co-Founder. In these positions, Dr. Coulie played an integral role in advancing the…

Dr. Grunberg is a Managing Director of Longitude Capital. Prior to joining Longitude Capital in 2012, Dr. Grunberg was a Principal at Rho Ventures and an Engagement Manager at McKinsey & Company. Dr. Grunberg is a board-certified physician in Internal Medicine and completed his residency at Cornell’s New York Presbyterian Hospital. He has maintained a…

Ted began his career with Merck & Co. in Clinical Pharmacology and Pulmonary-Immunology and eventually was responsible for other therapeutic areas within the company including Gastroenterology. Ted also worked at Covance, fostering an integrated approach to drug development, Vanderbilt School of Medicine in Molecular Toxicology and the Clinical and Translational Science Institute (CTSI) and joins…

Mahendra Shah, is a highly successful pharmaceutical entrepreneur and executive who has been with Vivo Capital, LLC since March 2010. He currently serving as managing director. Dr. Shah is the founder and executive chairman of Semnur Pharmaceuticals. He previously served as chairman of the board of Essentialis, and currently serves as a board member of…

Jeff Goldstein is a double lung transplant recipient (2003) and the Founding Member and President of the Lung Transplant Foundation (LTF). The LTF’s mission is to improve the lives of lung transplant recipients and is particularly interested in the development of therapies and technologies to treat BOS and rejection. Mr. Goldstein’s background is in business…

Tim Watkins is a Director of Clinical Research in Respiratory/Inflammation Therapeutics at Gilead Sciences. He has over a decade of experience in the biomedical and biopharmaceutical sectors, with clinical research spanning ARDS, trauma, sepsis, viral pneumonia and other aspects of inflammatory and respiratory diseases. At Gilead, Tim is responsible for the clinical development of drug…